The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems, providing an alternative to comparator products and lowering price ...
Netherlands-based argenx has published positive topline results from its ADAPT SERON trial of its market-leading drug for generalised myasthenia gravis (gMG) Vyvgart (efgartigimod). Significantly, the ...
Gemtesa is a prescription medication for adults with overactive bladder. It may help reduce symptoms like frequent urination and urge incontinence. Gemtesa is generally safe but may cause side effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback